HCWB · HCW Biologics Inc.
$3.45
-0.14 (-3.90%)
At close · Sep 1
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company believes that substantial doubt exists regarding its ability to continue as a going concern for at least 12 months from the date of issuance of the Company's condensed financial statements, without additional funding or financial support. After considering management's plan for financing and funds raised that are probable to occur within one year, as well as that the Company expects to continue to incur losses from operations for the foreseeable future, management concluded that the substantial doubt that existed in its going concern analysis as of June 30, 2026 was not alleviated.”View the 10-Q filed Aug 14, 2026
Market Cap
$6.26M
Shares
1.84M
HCW Biologics Inc. Earnings Call Transcripts
Quarterly earnings calls for HCW Biologics Inc. (HCWB), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
Earnings call
FY25 · Q3
2025-11-07
HCW Biologics Inc. (HCWB) Q3 2025 Earnings Call
Revenue
$15,606
▼ 96.3% YoY Diluted EPS
$-12.12
Gross margin
20.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-13
HCW Biologics Inc. (HCWB) Q1 2022 Earnings Call
Revenue
$3.12M
Diluted EPS
$-14.40
Gross margin
57.4%
Rev · 6q
Audio
Transcript
Slides
8-K10-Q
Showing 1–2 of 2 earnings calls
Key facts
CIK
1828673
CUSIP
40423R303
13F (30d)
11 filings
11 filers
Visit website
Investor relations